跳至主要内容
临床试验/NCT07216508
NCT07216508Enrolling By Invitation不适用

Post-discharge Glycemic Control After Liver Transplant and Impact on Transplant Outcomes

Icahn School of Medicine at Mount Sinai2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年10月13日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
40
试验地点
2
主要终点
Time in range

研究概览

简要总结

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

详细描述

Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospectively. Participants will be invited to wear another blinded sensor at 6 and 12 months.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL

排除标准

  • having a planned discharge to a rehabilitation or nursing facility,
  • a contraindication to sensor placement,
  • if discharge is anticipated to be >30 days post-transplant, or
  • if recent transplant also included a kidney or pancreas transplant

结局指标

主要结局

Time in range

时间窗: 28 days

Time in range 70-180mg/dL

次要结局

  • Percent time >180mg/dL(28 days)
  • Percent time >250mg/dL(28 days)
  • Percent time <70mg/dL(28 days)
  • Percent time <54mg/dL(28 days)
  • Transplant outcomes(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Grenye O'Malley

Associate Professor

Icahn School of Medicine at Mount Sinai

研究点 (2)

Loading locations...

相似试验